3 No-Brainer Growth Stocks to Buy in October
Smart investors are continually looking for new investment ideas. Sometimes, those ideas are so good that they're hard to pass up.
Three Motley Fool contributors think they've picked some stocks that fit the bill. Here's why they believe that Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer growth stocks to buy in October.
Prosper Junior Bakiny (Eli Lilly): Stock performance isn't always a reliable proxy for a company's financial results and prospects. But in the case of Eli Lilly, it most certainly is.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
433,75 €
-0,09 %
Die Community zeigt großes Interesse an Vertex Pharmaceuticals Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 459 € für Vertex Pharmaceuticals Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 433.75 €.
